col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: eLife Sciences Publications, Ltd.

265 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] eLife 2024―Oct―29 Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progression Matias A Medina, Francisco Fuentes-Villalobos, Claudio Quevedo, Felipe Aguilera, Raul Riquelme, Maria Luisa Rioseco, et al. (+8)
2 [GO] eLife 2024―Oct―03 Novel risk loci for COVID-19 hospitalization among admixed American populations Silvia Diz-de Almeida, Raquel Cruz, Andre D Luchessi, José M Lorenzo-Salazar, Miguel López de Heredia, Inés Quintela, et al. (+115)
3 [GO] eLife 2024―Aug―28 Recent evolutionary origin and localized diversity hotspots of mammalian coronaviruses Renan Maestri, Benoît Perez-Lamarque, Anna Zhukova, Hélène Morlon
4 [GO] eLife 2024―Jul―16 Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial Joanna C Porter, Jamie Inshaw, Vincente Joel Solis, Emma Denneny, Rebecca Evans, Mia I Temkin, et al. (+19)
5 [GO] eLife 2024―Jul―16 Associations of proton pump inhibitors with susceptibility to influenza, pneumonia, and COVID-19: Evidence from a large population-based cohort study Ruijie Zeng, Yuying Ma, Lijun Zhang, Dongling Luo, Rui Jiang, Huihuan Wu, et al. (+7)
6 [GO] eLife 2024―Jun―28 Modulation of biophysical properties of nucleocapsid protein in the mutant spectrum of SARS-CoV-2 Ai Nguyen, Huaying Zhao, Dulguun Myagmarsuren, Sanjana Srinivasan, Di Wu, Jiji Chen, et al. (+2)
7 [GO] eLife 2024―Jun―25 Hybrid immunity from SARS-CoV-2 infection and vaccination in Canadian adults: cohort study Patrick E Brown, Sze Hang Fu, Leslie Newcombe, Xuyang Tang, Nico Nagelkerke, H Chaim Birnboim, et al. (+15)
8 [GO] eLife 2024―Jun―12 Role of N343 glycosylation on the SARS-CoV-2 S RBD structure and co-receptor binding across variants of concern Callum M Ives, Linh Nguyen, Carl A Fogarty, Aoife M Harbison, Yves Durocher, John Klassen, Elisa Fadda
9 [GO] eLife 2024―May―30 Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease Kejia Zhang, Patrick Eldin, Jessica H Ciesla, Laurence Briant, Jenna M Lentini, Jillian Ramos, et al. (+3)
10 [GO] eLife 2024―May―08 Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies Xiuyuan Lu, Hiroki Hayashi, Eri Ishikawa, Yukiko Takeuchi, Julian Vincent Tabora Dychiao, Hironori Nakagami, Sho Yamasaki
11 [GO] eLife 2024―May―07 Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus Natalia E Ketaren, Fred D Mast, Peter C Fridy, Jean Paul Olivier, Tanmoy Sanyal, Andrej Sali, et al. (+3)
12 [GO] eLife 2024―May―07 Some mechanistic underpinnings of molecular adaptations of SARS-COV-2 spike protein by integrating candidate adaptive polymorphisms with protein dynamics Nicholas James Ose, Paul Campitelli, Tushar Modi, I Can Kazan, Sudhir Kumar, Sefika Banu Ozkan
13 [GO] eLife 2024―Apr―24 Altered transcriptomic immune responses of maintenance hemodialysis patients to the COVID-19 mRNA vaccine Yi-Shin Chang, Kai Huang, Jessica M Lee, Christen L Vagts, Christian Ascoli, Md-Ruhul Amin, et al. (+19)
14 [GO] eLife 2024―Apr―16 A retrospective cohort study of Paxlovid efficacy depending on treatment time in hospitalized COVID-19 patients Zhanwei Du, Lin Wang, Yuan Bai, Yunhu Liu, Eric HY Lau, Alison P Galvani, et al. (+3)
15 [GO] eLife 2024―Apr―04 Associations of proton pump inhibitors with susceptibility to influenza, pneumonia, and COVID-19: Evidence from a large population-based cohort study Ruijie Zeng, Yuying Ma, Lijun Zhang, Dongling Luo, Rui Jiang, Huihuan Wu, et al. (+7)
16 [GO] eLife 2024―Mar―27 Role of N343 glycosylation on the SARS-CoV-2 S RBD structure and co-receptor binding across variants of concern Callum M Ives, Linh Nguyen, Carl A Fogarty, Aoife M Harbison, Yves Durocher, John Klassen, Elisa Fadda
17 [GO] eLife 2024―Mar―20 Murine alveolar macrophages rapidly accumulate intranasally administered SARS-CoV-2 Spike protein leading to neutrophil recruitment and damage Chung Park, Il-Young Hwang, Serena Li-Sue Yan, Sinmanus Vimonpatranon, Danlan Wei, Don Van Ryk, et al. (+4)
18 [GO] eLife 2024―Mar―07 Exploring factors shaping antibiotic resistance patterns in Streptococcus pneumoniae during the 2020 COVID-19 pandemic Aleksandra Kovacevic, David RM Smith, Eve Rahbé, Sophie Novelli, Paul Henriot, Emmanuelle Varon, et al. (+4)
19 [GO] eLife 2024―Feb―28 Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamster Julia R Port, Dylan H Morris, Jade C Riopelle, Claude Kwe Yinda, Victoria A Avanzato, Myndi G Holbrook, et al. (+11)
20 [GO] eLife 2024―Feb―28 Disentangling the relationship between cancer mortality and COVID-19 in the US Chelsea L Hansen, Cécile Viboud, Lone Simonsen
21 [GO] eLife 2024―Feb―28 Recent evolutionary origin and localized diversity hotspots of mammalian coronaviruses Renan Maestri, Benoît Perez-Lamarque, Anna Zhukova, Hélène Morlon
22 [GO] eLife 2024―Feb―28 Effect of an enhanced public health contact tracing intervention on the secondary transmission of SARS-CoV-2 in educational settings: The four-way decomposition analysis Olivera Djuric, Elisabetta Larosa, Mariateresa Cassinadri, Silvia Cilloni, Eufemia Bisaccia, Davide Pepe, et al. (+7)
23 [GO] eLife 2024―Feb―20 Transcriptional regulation of SARS-CoV-2 receptor ACE2 by SP1 Hui Han, Rong-Hua Luo, Xin-Yan Long, Li-Qiong Wang, Qian Zhu, Xin-Yue Tang, et al. (+4)
24 [GO] eLife 2024―Feb―14 Novel risk loci for COVID-19 hospitalization among admixed American populations Silvia Diz-de Almeida, Raquel Cruz, Andre D Luchessi, José M Lorenzo-Salazar, Miguel López de Heredia, Inés Quintela, et al. (+115)
25 [GO] eLife 2024―Feb―06 Modulation of biophysical properties of nucleocapsid protein in the mutant spectrum of SARS-CoV-2 Ai Nguyen, Huaying Zhao, Dulguun Myagmarsuren, Sanjana Srinivasan, Di Wu, Jiji Chen, et al. (+2)
26 [GO] eLife 2024―Feb―02 Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progression Matias A Medina, Francisco Fuentes-Villalobos, Claudio Quevedo, Felipe Aguilera, Raul Riquelme, Maria Luisa Rioseco, et al. (+8)
27 [GO] eLife 2024―Jan―24 Hyperglycemia induced cathepsin L maturation linked to diabetic comorbidities and COVID-19 mortality Qiong He, Miao-Miao Zhao, Ming-Jia Li, Xiao-Ya Li, Jian-Min Jin, Ying-Mei Feng, et al. (+4)
28 [GO] eLife 2023―Dec―21 Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16 Huan Wang, Syed RA Rizvi, Danni Dong, Jiaqi Lou, Qian Wang, Watanyoo Sopipong, et al. (+5)
29 [GO] eLife 2023―Dec―12 Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic Miriam Elfström, Penelope Grace Gray, Joakim Dillner
30 [GO] eLife 2023―Nov―22 Lys417 acts as a molecular switch that regulates the conformation of SARS-CoV-2 spike protein Qibin Geng, Yushun Wan, Fu-Chun Hsueh, Jian Shang, Gang Ye, Fan Bu, et al. (+4)
31 [GO] eLife 2023―Nov―21 Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform Enja Tatjana Kipfer, David Hauser, Martin J Lett, Fabian Otte, Lorena Urda, Yuepeng Zhang, et al. (+4)
32 [GO] eLife 2023―Nov―13 Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease Kejia Zhang, Patrick Eldin, Jessica H Ciesla, Laurence Briant, Jenna M Lentini, Jillian Ramos, et al. (+3)
33 [GO] eLife 2023―Nov―09 Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus Natalia E Ketaren, Fred D Mast, Peter C Fridy, Jean Paul Olivier, Tanmoy Sanyal, Andrej Sali, et al. (+3)
34 [GO] eLife 2023―Nov―06 Some mechanistic underpinnings of molecular adaptations of SARS-COV-2 spike protein by integrating candidate adaptive polymorphisms with protein dynamics Nicholas James Ose, Paul Campitelli, Tushar Modi, I Can Kazan, Sudhir Kumar, Sefika Banu Ozkan
35 [GO] eLife 2023―Oct―17 Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: a COVID-19 and cancer consortium (CCC19) cohort study Gayathri Nagaraj, Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M Kuderer, David M Aboulafia, et al. (+91)
36 [GO] eLife 2023―Oct―13 A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination Louiza S Velentzis, Megan A Smith, James Killen, Julia ML Brotherton, Rebecca Guy, Karen Canfell
37 [GO] eLife 2023―Oct―13 Single-nuclei characterization of pervasive transcriptional signatures across organs in response to COVID-19 Alejandro A Granados, Simon Bucher, Hanbing Song, Aditi Agrawal, Ann T Chen, Tien Peng, et al. (+4)
38 [GO] eLife 2023―Oct―11 Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies Xiuyuan Lu, Hiroki Hayashi, Eri Ishikawa, Yukiko Takeuchi, Julian Vincent Tabora Dychiao, Hironori Nakagami, Sho Yamasaki
39 [GO] eLife 2023―Sep―22 The importance of patient-partnered research in addressing long COVID: Takeaways for biomedical research study design from the RECOVER Initiative’s Mechanistic Pathways taskforce C Kim, Benjamin Chen, Sindhu Mohandas, Jalees Rehman, Zaki A Sherif, K Coombs
40 [GO] eLife 2023―Sep―21 Within-host diversity improves phylogenetic and transmission reconstruction of SARS-CoV-2 outbreaks Arturo Torres Ortiz, Michelle Kendall, Nathaniel Storey, James Hatcher, Helen Dunn, Sunando Roy, et al. (+7)
41 [GO] eLife 2023―Sep―12 A rapid review of COVID-19’s global impact on breast cancer screening participation rates and volumes from January to December 2020 Reagan Lee, Wei Xu, Marshall Dozier, Ruth McQuillan, Evropi Theodoratou, Jonine Figueroa
42 [GO] eLife 2023―Sep―04 Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in Federally Qualified Health Centers: A mixed methods study Lindsay Fuzzell, Paige Lake, Naomi C Brownstein, Holly B Fontenot, Ashley Whitmer, Alexandra Michel, et al. (+5)
43 [GO] eLife 2023―Sep―01 Examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic: a mixed methods assessment Lindsay Fuzzell, Naomi C Brownstein, Holly B Fontenot, Paige W Lake, Alexandra Michel, Ashley Whitmer, et al. (+4)
44 [GO] eLife 2023―Aug―29 The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2 Hsiao-Fan Chen, Wei-Jan Wang, Chung-Yu Chen, Wei-Chao Chang, Po-Ren Hsueh, Shin-Lei Peng, et al. (+6)
45 [GO] eLife 2023―Aug―24 Development and validation of COEWS (COVID-19 Early Warning Score) for hospitalized COVID-19 with laboratory features: a multicontinental retrospective study Riku Klén, Ivan A Huespe, Felipe Aníbal Gregalio, Antonio Lalueza Lalueza Blanco, Miguel Pedrera Jimenez, Noelia Garcia Barrio, et al. (+8)
46 [GO] eLife 2023―Aug―22 Electronic data review, client reminders, and expanded clinic hours for improving cervical cancer screening rates after COVID-19 pandemic shutdowns: a multi-component quality improvement program Sue Ghosh, Jackie Fantes, Karin Leschly, Julio Mazul, Rebecca B Perkins
47 [GO] eLife 2023―Aug―18 A review of HPV and HBV vaccine hesitancy, intention, and uptake in the era of social media and COVID-19 Emily K Vraga, Sonya S Brady, Chloe Gansen, Euna Mehnaz Khan, Sarah L Bennis, Madalyn Nones, et al. (+3)
48 [GO] eLife 2023―Aug―17 Nation-wide mammography screening participation in Denmark during the COVID-19 pandemic: an observational study Tina Bech Olesen, Henry Jensen, Henrik Møller, Jens Winther Jensen, Berit Andersen, Ilse Vejborg, Sisse Helle Njor
49 [GO] eLife 2023―Aug―11 Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform Enja Tatjana Kipfer, David Hauser, Martin J Lett, Fabian Otte, Lorena Urda, Yuepeng Zhang, et al. (+4)
50 [GO] eLife 2023―Aug―10 Healthcare in England was affected by the COVID-19 pandemic across the pancreatic cancer pathway: A cohort study using OpenSAFELY-TPP Agnieszka Lemanska, Colm Andrews, Louis Fisher, Seb Bacon, Adam E Frampton, Amir Mehrkar, et al. (+7)
51 [GO] eLife 2023―Aug―03 Association between Bisphosphonate use and COVID-19 related outcomes Jeffrey Thompson, Yidi Wang, Tobias Dreischulte, Olga Barreiro, Rodrigo J Gonzalez, Pavel Hanč, et al. (+6)
52 [GO] eLife 2023―Jul―31 SARS-CoV-2 uses CD4 to infect T helper lymphocytes Natalia S Brunetti, Gustavo G Davanzo, Diogo de Moraes, Allan JR Ferrari, Gabriela F Souza, Stéfanie Primon Muraro, et al. (+70)
53 [GO] eLife 2023―Jul―27 Comparing the evolutionary dynamics of predominant SARS-CoV-2 virus lineages co-circulating in Mexico Hugo G Castelán-Sánchez, Luis Delaye, Rhys PD Inward, Simon Dellicour, Bernardo Gutierrez, Natalia Martinez de la Vina, et al. (+21)
54 [GO] eLife 2023―Jul―27 Eleven key measures for monitoring general practice clinical activity during COVID-19: A retrospective cohort study using 48 million adults’ primary care records in England through OpenSAFELY Louis Fisher, Helen J Curtis, Richard Croker, Milan Wiedemann, Victoria Speed, Christopher Wood, et al. (+42)
55 [GO] eLife 2023―Jul―18 Association of close-range contact patterns with SARS-CoV-2: a household transmission study Jackie Kleynhans, Lorenzo Dall'Amico, Laetitia Gauvin, Michele Tizzoni, Lucia Maloma, Sibongile Walaza, et al. (+7)
56 [GO] eLife 2023―Jul―07 Recapitulation of pathophysiological features of AD in SARS-CoV-2-infected subjects Elizabeth Griggs, Kyle Trageser, Sean Naughton, Eun-Jeong Yang, Brian Mathew, Grace Van Hyfte, et al. (+6)
57 [GO] eLife 2023―Jul―06 Meta-research: The effect of the COVID-19 pandemic on the gender gap in research productivity within academia Kiran GL Lee, Adele Mennerat, Dieter Lukas, Hannah L Dugdale, Antica Culina
58 [GO] eLife 2023―Jun―28 Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals Mariam El-Zein, Rami Ali, Eliya Farah, Sarah Botting-Provost, Eduardo L Franco
59 [GO] eLife 2023―Jun―27 The Impact of COVID-19 on cancer screening and treatment in older adults: the multiethnic cohort study Victoria P Mak, Kami White, Lynne R Wilkens, Iona Cheng, Christopher A Haiman, Loic Le Marchand
60 [GO] eLife 2023―Jun―23 Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16 Huan Wang, Syed RA Rizvi, Danni Dong, Jiaqi Lou, Qian Wang, Watanyoo Sopipong, et al. (+5)
61 [GO] eLife 2023―Jun―14 Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial Joanna C Porter, Jamie Inshaw, Vincente Joel Solis, Emma Denneny, Rebecca Evans, Mia I Temkin, et al. (+19)
62 [GO] eLife 2023―Jun―13 Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months Marianna Santopaolo, Michaela Gregorova, Fergus Hamilton, David Arnold, Anna Long, Aurora Lacey, et al. (+19)
63 [GO] eLife 2023―Jun―06 Murine alveolar macrophages rapidly accumulate intranasally administered SARS-CoV-2 Spike protein leading to neutrophil recruitment and damage Chung Park, Il-Young Hwang, Serena Li-Sue Yan, Sinmanus Vimonpatranon, Danlan Wei, Don Van Ryk, et al. (+4)
64 [GO] eLife 2023―May―30 Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamster Julia R Port, Dylan H Morris, Jade C Riopelle, Claude Kwe Yinda, Victoria A Avanzato, Myndi G Holbrook, et al. (+11)
65 [GO] eLife 2023―May―26 Perceived barriers to cervical cancer screening and motivators for at-home human papillomavirus self-sampling during the COVID-19 pandemic: Results from a telephone survey Susan L Parker, Ashish A Deshmukh, Baojiang Chen, David R Lairson, Maria Daheri, Sally W Vernon, Jane R Montealegre
66 [GO] eLife 2023―May―26 Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC) Sindhu Mohandas, Prasanna Jagannathan, Timothy J Henrich, Zaki A Sherif, Christian Bime, Erin Quinlan, et al. (+3)
67 [GO] eLife 2023―May―16 Quantification of impact of COVID-19 pandemic on cancer screening programmes - a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand Eric Lucas, Raul Murillo, Silvina Arrossi, Martin Bárcena, Youssef Chami, Ashrafun Nessa, et al. (+5)
68 [GO] eLife 2023―May―04 Viral persistence, reactivation, and mechanisms of long COVID Benjamin Chen, Boris Julg, Sindhu Mohandas, Steven B Bradfute
69 [GO] eLife 2023―May―02 Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic Pedro Nascimento de Lima, Rosita van den Puttelaar, Anne I Hahn, Matthias Harlass, Nicholson Collier, Jonathan Ozik, et al. (+3)
70 [GO] eLife 2023―Apr―26 Phylodynamics of SARS-CoV-2 in France, Europe and the world in 2020 Romain Coppée, François Blanquart, Aude Jary, Valentin Leducq, Valentine Marie Ferré, Anna Maria Franco Yusti, et al. (+9)
71 [GO] eLife 2023―Apr―21 Predictive performance of multi-model ensemble forecasts of COVID-19 across European nations Katharine Sherratt, Hugo Gruson, Rok Grah, Helen Johnson, Rene Niehus, Bastian Prasse, et al. (+123)
72 [GO] eLife 2023―Apr―18 Point of View: COVID-19 as a catalyst for reimagining cervical cancer prevention Rebecca Luckett, Sarah Feldman, Yin Ling Woo, Anna-Barbara Moscicki, Anna R Giuliano, Silvia de Sanjose, et al. (+9)
73 [GO] eLife 2023―Apr―06 A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia Carolyn Nickson, Megan A Smith, Eleonora Feletto, Louiza S Velentzis, Kate Broun, Sabine Deij, et al. (+10)
74 [GO] eLife 2023―Apr―04 An umbrella review of systematic reviews on the impact of the COVID-19 pandemic on cancer prevention and management, and patient needs Taulant Muka, Joshua JX Li, Sahar J Farahani, John PA Ioannidis
75 [GO] eLife 2023―Apr―04 Zooanthroponotic transmission of SARS-CoV-2 and host-specific viral mutations revealed by genome-wide phylogenetic analysis Sana Naderi, Peter E Chen, Carmen Lia Murall, Raphael Poujol, Susanne Kraemer, Bradley S Pickering, et al. (+2)
76 [GO] eLife 2023―Mar―28 Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial Astha Thakkar, Kith Pradhan, Benjamin Duva, Juan Manuel Carreno, Srabani Sahu, Victor Thiruthuvanathan, et al. (+17)
77 [GO] eLife 2023―Mar―22 Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) Zaki A Sherif, Christian R Gomez, Thomas J Connors, Timothy J Henrich, William Brian Reeves
78 [GO] eLife 2023―Mar―21 Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses Rui P Silva, Yimin Huang, Annalee W Nguyen, Ching-Lin Hsieh, Oladimeji S Olaluwoye, Tamer S Kaoud, et al. (+20)
79 [GO] eLife 2023―Mar―21 Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study Mette Hartmann Nonboe, George Napolitano, Jeppe Bennekou Schroll, Ilse Vejborg, Marianne Waldstrøm, Elsebeth Lynge
80 [GO] eLife 2023―Mar―17 Timeline of changes in spike conformational dynamics in emergent SARS-CoV-2 variants reveal progressive stabilization of trimer stalk with altered NTD dynamics Sean M Braet, Theresa SC Buckley, Varun Venkatakrishnan, Kim-Marie A Dam, Pamela J Bjorkman, Ganesh S Anand
81 [GO] eLife 2023―Mar―16 Evaluation of antibody kinetics and durability in health individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): a cross-sectional and cohort study in Zhejiang, China Hangjie Zhang, Qianhui Hua, Nani Nani Xu, Xinpei Zhang, Bo Chen, Xijun Ma, et al. (+11)
82 [GO] eLife 2023―Feb―23 Reducing societal impacts of SARS-CoV-2 interventions through subnational implementation Mark M Dekker, Luc E Coffeng, Frank P Pijpers, Debabrata Panja, Sake J de Vlas
83 [GO] eLife 2023―Feb―23 The effect of variation of individual infectiousness on SARS-CoV-2 transmission in households Tim K Tsang, Xiaotong Huang, Can Wang, Sijie Chen, Bingyi Yang, Simon Cauchemez, Benjamin John Cowling
84 [GO] eLife 2023―Feb―22 Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022 Wha-Eum Lee, Sang Woo Park, Daniel M Weinberger, Donald Olson, Lone Simonsen, Bryan T Grenfell, Cécile Viboud
85 [GO] eLife 2023―Feb―21 Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV) William HK Schilling, Podjanee Jittamala, James A Watson, Maneerat Ekkapongpisit, Tanaya Siripoon, Thundon Ngamprasertchai, et al. (+31)
86 [GO] eLife 2023―Feb―13 The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution Alief Moulana, Thomas Dupic, Angela M Phillips, Jeffrey Chang, Anne A Roffler, Allison J Greaney, et al. (+3)
87 [GO] eLife 2023―Feb―10 Regulatory dissection of the severe COVID-19 risk locus introgressed by Neanderthals Evelyn Jagoda, Davide Marnetto, Gayani Senevirathne, Victoria Gonzalez, Kaushal Baid, Francesco Montinaro, et al. (+7)
88 [GO] eLife 2023―Feb―07 Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period Hiba Dagher, Anne-Marie Chaftari, Ishwaria M Subbiah, Alexandre E Malek, Ying Jiang, Peter Lamie, et al. (+14)
89 [GO] eLife 2023―Feb―03 The impact of the COVID-19 pandemic on Italian population-based cancer screening activities and test coverage: Results from national cross-sectional repeated surveys in 2020 Paolo Giorgi Rossi, Giuliano Carrozzi, Patrizia Falini, Letizia Sampaolo, Giuseppe Gorini, Manuel Zorzi, et al. (+7)
90 [GO] eLife 2023―Feb―02 Coordinated evolution at amino acid sites of SARS-CoV-2 spike Alexey Dmitrievich Neverov, Gennady Fedonin, Anfisa Popova, Daria Bykova, Georgii Bazykin
91 [GO] eLife 2023―Jan―31 The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: A scoping review of systematic reviews and meta-analyses Parker Tope, Eliya Farah, Rami Ali, Mariam El-Zein, Wilson H Miller, Eduardo L Franco
92 [GO] eLife 2023―Jan―30 International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: impact of risk factors and treatment modalities on survivorship Issam I Raad, Ray Hachem, Nigo Masayuki, Tarcila Datoguia, Hiba Dagher, Ying Jiang, et al. (+46)
93 [GO] eLife 2023―Jan―27 Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open label interventional study Avner Ehrlich, Konstantinos Ioannidis, Makram Nasar, Ismaeel Abu Alkian, Yuval Daskal, Nofar Atari, et al. (+18)
94 [GO] eLife 2023―Jan―25 Nation-wide participation in FIT-based colorectal cancer screening in Denmark during the COVID-19 pandemic: An observational study Tina Bech Olesen, Henry Jensen, Henrik Møller, Jens Winther Jensen, Berit Andersen, Morten Rasmussen
95 [GO] eLife 2023―Jan―25 The SARS-CoV-2 accessory protein Orf3a is not an ion channel, but does interact with trafficking proteins Alexandria N Miller, Patrick R Houlihan, Ella Matamala, Deny Cabezas-Bratesco, Gi Young Lee, Ben Cristofori-Armstrong, et al. (+8)
96 [GO] eLife 2023―Jan―24 Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies Nathan J Cheetham, Milla Kibble, Andrew Wong, Richard J Silverwood, Anika Knuppel, Dylan M Williams, et al. (+31)
97 [GO] eLife 2023―Jan―20 Participation in the nation-wide cervical cancer screening programme in Denmark during the COVID-19 pandemic: an observational study Tina Bech Olesen, Henry Jensen, Henrik Møller, Jens Winther Jensen, Marianne Waldstrøm, Berit Andersen
98 [GO] eLife 2023―Jan―19 Future COVID19 surges prediction based on SARS-CoV-2 mutations surveillance Fares Z Najar, Evan Linde, Chelsea L Murphy, Veniamin A Borin, Haun Wang, Shozeb Haider, Pratul K Agarwal
99 [GO] eLife 2023―Jan―18 A modelling approach to estimate the transmissibility of SARS-CoV-2 during periods of high, low, and zero case incidence Nick Golding, David J Price, Gerard Ryan, Jodie McVernon, James M McCaw, Freya M Shearer
100 [GO] eLife 2022―Dec―21 Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19 Hiba Dagher, Anne-Marie Chaftari, Patricia Mulanovich, Ying Jiang, Ray Hachem, Alexandre E Malek, et al. (+3)
101 [GO] eLife 2022―Dec―20 Cross-talk between red blood cells and plasma influences blood flow and omics phenotypes in severe COVID-19 Steffen M Recktenwald, Greta Simionato, Marcelle GM Lopes, Fabia Gamboni, Monika Dzieciatkowska, Patrick Meybohm, et al. (+6)
102 [GO] eLife 2022―Nov―21 SARS-CoV-2-specific CD4+ and CD8+ T cell responses can originate from cross-reactive CMV-specific T cells Cilia R Pothast, Romy C Dijkland, Melissa Thaler, Renate S Hagedoorn, Michel GD Kester, Anne K Wouters, et al. (+5)
103 [GO] eLife 2022―Nov―16 Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: a retrospective cohort study James A Hay, Stephen M Kissler, Joseph R Fauver, Christina Mack, Caroline G Tai, Radhika M Samant, et al. (+19)
104 [GO] eLife 2022―Nov―07 Revealing druggable cryptic pockets in the Nsp1 of SARS-CoV-2 and other β-coronaviruses by simulations and crystallography Alberto Borsatto, Obaeda Akkad, Ioannis Galdadas, Shumeng Ma, Shymaa Damfo, Shozeb Haider, et al. (+3)
105 [GO] eLife 2022―Nov―07 Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern Fulvia Mazzaferri, Massimo Mirandola, Alessia Savoldi, Pasquale De Nardo, Matteo Morra, Maela Tebon, et al. (+14)
106 [GO] eLife 2022―Oct―25 HIV skews the SARS-CoV-2 B cell response toward an extrafollicular maturation pathway Robert Krause, Jumari Snyman, Hwa Shi-Hsia, Daniel Muema, Farina Karim, Yashica Ganga, et al. (+17)
107 [GO] eLife 2022―Oct―21 COVID-19 cluster size and transmission rates in schools from crowdsourced case reports Paul Tupper, Shraddha Pai, Caroline Colijn
108 [GO] eLife 2022―Oct―20 Structure of SARS-CoV-2 M protein in lipid nanodiscs Kimberly A Dolan, Mandira Dutta, David M Kern, Abhay Kotecha, Gregory A Voth, Stephen G Brohawn
109 [GO] eLife 2022―Oct―19 Targeted genomic sequencing with probe capture for discovery and surveillance of coronaviruses in bats Kevin S Kuchinski, Kara D Loos, Danae M Suchan, Jennifer N Russell, Ashton N Sies, Charles Kumakamba, et al. (+20)
110 [GO] eLife 2022―Oct―17 Genetically predicted high IGF-1 levels showed protective effects on COVID-19 susceptibility and hospitalization: a Mendelian randomisation study with data from 60 studies across 25 countries Xinxuan Li, Yajing Zhou, Shuai Yuan, Xuan Zhou, Lijuan Wang, Jing Sun, et al. (+10)
111 [GO] eLife 2022―Oct―17 Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction Nardus Mollentze, Deborah Keen, Uuriintuya Munkhbayar, Roman Biek, Daniel G Streicker
112 [GO] eLife 2022―Oct―14 Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study Zicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, Prabhu S Arunachalam, Diego AM Mori, Karen B Jacobson, et al. (+21)
113 [GO] eLife 2022―Oct―13 Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial Nicolás MS Gálvez, Gaspar A Pacheco, Bárbara M Schultz, Felipe Melo-González, Jorge A Soto, Luisa F Duarte, et al. (+33)
114 [GO] eLife 2022―Oct―11 A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions Emily A Burger, Inge MCM de Kok, James F O'Mahony, Matejka Rebolj, Erik EL Jansen, Daniel D de Bondt, et al. (+7)
115 [GO] eLife 2022―Oct―05 An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients Bronner P Gonçalves, Matthew Hall, Waasila Jassat, Valeria Balan, Srinivas Murthy, Christiana Kartsonaki, et al. (+40)
116 [GO] eLife 2022―Oct―04 How should COVID-19 vaccines be distributed between the Global North and South: a discrete choice experiment in six European countries Janina I Steinert, Henrike Sternberg, Giuseppe A Veltri, Tim Büthe
117 [GO] eLife 2022―Sep―22 SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: A serial cross-sectional study Carlos A Prete Junior, Lewis Fletcher Buss, Charles Whittaker, Tassila Salomon, Marcio K Oikawa, Rafael HM Pereira, et al. (+39)
118 [GO] eLife 2022―Sep―13 Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: multicenter, prospective study Oliver Stirrup, James Blackstone, Fiona Mapp, Alyson MacNeil, Monica Panca, Alison Holmes, et al. (+42)
119 [GO] eLife 2022―Sep―06 Correction: Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229e Kathryn E Kistler, Trevor Bedford
120 [GO] eLife 2022―Aug―25 A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants Jing Zhang, Zi Bo Han, Yu Liang, Xue Feng Zhang, Yu Qin Jin, Li Fang Du, et al. (+19)
121 [GO] eLife 2022―Aug―08 Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2 Jana Sanne Huisman, Jérémie Scire, Daniel C Angst, Jinzhou Li, Richard A Neher, Marloes H Maathuis, et al. (+2)
122 [GO] eLife 2022―Aug―01 The unmitigated profile of COVID-19 infectiousness Ron Sender, Yinon Bar-On, Sang Woo Park, Elad Noor, Jonathan Dushoff, Ron Milo
123 [GO] eLife 2022―Jul―26 Developing evolution-resistant drugs for COVID-19 Daniel M Weinreich
124 [GO] eLife 2022―Jul―26 Surveying the experience of postdocs in the United States before and during the COVID-19 pandemic Andréanne Morin, Britney A Helling, Seetha Krishnan, Laurie E Risner, Nykia D Walker, Nancy B Schwartz
125 [GO] eLife 2022―Jul―25 Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition Thandeka Nkosi, Caroline Chasara, Andrea O Papadopoulos, Tiza L Nguni, Farina Karim, Mahomed-Yunus S Moosa, et al. (+5)
126 [GO] eLife 2022―Jul―19 Reconstruction of transmission chains of SARS-CoV-2 amidst multiple outbreaks in a geriatric acute-care hospital: a combined retrospective epidemiological and genomic study Mohamed Abbas, Anne Cori, Samuel Cordey, Florian Laubscher, Tomás Robalo Nunes, Ashleigh Myall, et al. (+9)
127 [GO] eLife 2022―Jul―15 Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273 Niels JM Verstegen, Ruth R Hagen, Jet van den Dijssel, Lisan H Kuijper, Christine Kreher, Thomas Ashhurst, et al. (+23)
128 [GO] eLife 2022―Jul―08 Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection Marie Alexandre, Romain Marlin, Mélanie Prague, Severin Coleon, Nidhal Kahlaoui, Sylvain Cardinaud, et al. (+17)
129 [GO] eLife 2022―Jul―05 Controlling SARS-CoV-2 in schools using repetitive testing strategies Andrea Torneri, Lander Willem, Vittoria Colizza, Cécile Kremer, Christelle Meuris, Gilles Darcis, et al. (+2)
130 [GO] eLife 2022―Jul―04 Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine Lea Krutzke, Reinhild Rösler, Ellen Allmendinger, Tatjana Engler, Sebastian Wiese, Stefan Kochanek
131 [GO] eLife 2022―Jul―04 Investigating the relationship of COVID-19 related stress and media consumption with schizotypy, depression, and anxiety in cross-sectional surveys repeated throughout the pandemic in Germany and the UK Sarah Daimer, Lorenz L Mihatsch, Sharon AS Neufeld, Graham K Murray, Franziska Knolle
132 [GO] eLife 2022―Jun―28 Taking on SARS-CoV-2 Paola Kučan Brlić, Ilija Brizić
133 [GO] eLife 2022―Jun―23 Host chitinase 3-like-1 is a universal therapeutic target for SARS-CoV-2 viral variants in COVID-19 Suchitra Kamle, Bing Ma, Chang Min Lee, Gail Schor, Yang Zhou, Chun Geun Lee, Jack A Elias
134 [GO] eLife 2022―Jun―21 Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination Shaun Truelove, Claire P Smith, Michelle Qin, Luke C Mullany, Rebecca K Borchering, Justin Lessler, et al. (+54)
135 [GO] eLife 2022―Jun―20 Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms Julia M Flynn, Neha Samant, Gily Schneider-Nachum, David T Bakan, Nese Kurt Yilmaz, Celia A Schiffer, et al. (+3)
136 [GO] eLife 2022―Jun―14 Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: a retrospective genomic study Charles N Agoti, Lynette Isabella Ochola-Oyier, Simon Dellicour, Khadija Said Mohammed, Arnold W Lambisia, Zaydah R de Laurent, et al. (+30)
137 [GO] eLife 2022―Jun―10 Impact of the COVID-19 pandemic on breast cancer screening indicators in a Spanish population-based program: a cohort study Guillermo Bosch, Margarita Posso, Javier Louro, Marta Roman, Miquel Porta, Xavier Castells, Francesc Macià
138 [GO] eLife 2022―Jun―06 Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells Ana CG Salina, Douglas dos-Santos, Tamara S Rodrigues, Marlon Fortes-Rocha, Edismauro G Freitas-Filho, Daniel L Alzamora-Terrel, et al. (+37)
139 [GO] eLife 2022―May―19 Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants François Blanquart, Nathanaël Hozé, Benjamin John Cowling, Florence Débarre, Simon Cauchemez
140 [GO] eLife 2022―May―19 SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies Ceri Alan Fielding, Pragati Sabberwal, James C Williamson, Edward JD Greenwood, Thomas WM Crozier, Wioleta Zelek, et al. (+15)
141 [GO] eLife 2022―May―17 Development and evaluation of a machine learning-based in-hospital COVID-19 disease outcome predictor (CODOP): A multicontinental retrospective study Riku Klén, Disha Purohit, Ricardo Gómez-Huelgas, José Manuel Casas-Rojo, Juan Miguel Antón-Santos, Jesús Millán Núñez-Cortés, et al. (+22)
142 [GO] eLife 2022―May―09 A LAMP sequencing approach for high-throughput co-detection of SARS-CoV-2 and influenza virus in human saliva Robert Warneford-Thomson, Parisha P Shah, Patrick Lundgren, Jonathan Lerner, Jason Morgan, Antonio Davila, et al. (+6)
143 [GO] eLife 2022―Mar―24 Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2 Mohammad Afsar, Rohan Narayan, Md Noor Akhtar, Deepakash Das, Huma Rahil, Santhosh Kambaiah Nagaraj, et al. (+3)
144 [GO] eLife 2022―Mar―24 Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike Marco A Díaz-Salinas, Qi Li, Monir Ejemel, Leonid Yurkovetskiy, Jeremy Luban, Kuang Shen, et al. (+2)
145 [GO] eLife 2022―Mar―24 The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein Hisham M Dokainish, Suyong Re, Takaharu Mori, Chigusa Kobayashi, Jaewoon Jung, Yuji Sugita
146 [GO] eLife 2022―Mar―23 Post-acute sequelae of COVID-19: A metabolic perspective Philipp E Scherer, John P Kirwan, Clifford J Rosen
147 [GO] eLife 2022―Mar―16 Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry Edward R Kastenhuber, Marisa Mercadante, Benjamin Nilsson-Payant, Jared L Johnson, Javier A Jaimes, Frauke Muecksch, et al. (+7)
148 [GO] eLife 2022―Mar―16 Meta-Research: Individual-level researcher data confirm the widening gender gap in publishing rates during COVID-19 Emil Bargmann Madsen, Mathias Wullum Nielsen, Josefine Bjørnholm, Reshma Jagsi, Jens Peter Andersen
149 [GO] eLife 2022―Mar―16 SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome Michela Zaffagni, Jenna M Harris, Ines L Patop, Nagarjuna Reddy Pamudurti, Sinead Nguyen, Sebastian Kadener
150 [GO] eLife 2022―Mar―15 Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike Andrew R Crowley, Harini Natarajan, Andrew P Hederman, Carly A Bobak, Joshua A Weiner, Wendy Wieland-Alter, et al. (+11)
151 [GO] eLife 2022―Mar―11 Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection Noah J Silverstein, Yetao Wang, Zachary Manickas-Hill, Claudia Carbone, Ann Dauphin, Brittany P Boribong, et al. (+11)
152 [GO] eLife 2022―Feb―28 Ribosome profiling of porcine reproductive and respiratory syndrome virus reveals novel features of viral gene expression Georgia M Cook, Katherine Brown, Pengcheng Shang, Yanhua Li, Lior Soday, Adam M Dinan, et al. (+5)
153 [GO] eLife 2022―Feb―22 SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern David W Hawman, Kimberly Meade-White, Jacob Archer, Shanna S Leventhal, Drew Wilson, Carl Shaia, et al. (+9)
154 [GO] eLife 2022―Feb―16 Effect of cancer on outcome of COVID-19 patients: a systematic review and meta-analysis of studies of unvaccinated patients Giulia Di Felice, Giovanni Visci, Federica Teglia, Marco Angelini, Paolo Boffetta
155 [GO] eLife 2022―Feb―09 Inference of the SARS-CoV-2 generation time using UK household data William Stephen Hart, Sam Abbott, Akira Endo, Joel Hellewell, Elizabeth Miller, Nick Andrews, et al. (+3)
156 [GO] eLife 2022―Feb―08 Investigating phenotypes of pulmonary COVID-19 recovery: A longitudinal observational prospective multicenter trial Thomas Sonnweber, Piotr Tymoszuk, Sabina Sahanic, Anna Boehm, Alex Pizzini, Anna Luger, et al. (+14)
157 [GO] eLife 2022―Jan―27 Vaccine-induced COVID-19 mimicry syndrome Eric Kowarz, Lea Krutzke, Marius Külp, Patrick Streb, Patrizia Larghero, Jennifer Reis, et al. (+4)
158 [GO] eLife 2022―Jan―24 Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection Meghan E Garrett, Jared G Galloway, Caitlin Wolf, Jennifer K Logue, Nicholas Franko, Helen Y Chu, et al. (+2)
159 [GO] eLife 2022―Jan―20 What triggers inflammation in COVID-19? Tomohiro Sawa, Takaaki Akaike
160 [GO] eLife 2022―Jan―13 ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology Riem Gawish, Philipp Starkl, Lisabeth Pimenov, Anastasiya Hladik, Karin Lakovits, Felicitas Oberndorfer, et al. (+18)
161 [GO] eLife 2022―Jan―11 Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection Zaigham Abbas Rizvi, Rajdeep Dalal, Srikanth Sadhu, Akshay Binayke, Jyotsna Dandotiya, Yashwant Kumar, et al. (+11)
162 [GO] eLife 2021―Dec―20 Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor Tümay Capraz, Nikolaus Ferdinand Kienzl, Elisabeth Laurent, Jan W Perthold, Esther Föderl-Höbenreich, Clemens Grünwald-Gruber, et al. (+10)
163 [GO] eLife 2021―Dec―10 Add mass spectrometry to the pandemic toolbox Bart Van Puyvelde, Maarten Dhaenens
164 [GO] eLife 2021―Nov―25 Neutrophil-mediated oxidative stress and albumin structural damage predict COVID-19-associated mortality Mohamed A Badawy, Basma A Yasseen, Riem M El-Messiery, Engy A Abdel-Rahman, Aya A Elkhodiry, Azza G Kamel, et al. (+14)
165 [GO] eLife 2021―Nov―25 The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice Rafael Bayarri-Olmos, Laust Bruun Johnsen, Manja Idorn, Line S Reinert, Anne Rosbjerg, Søren Vang, et al. (+7)
166 [GO] eLife 2021―Nov―23 Data-driven methodology for discovery and response to pulmonary symptomology in hypertension through statistical learning and data mining: Application to COVID-19 related pharmacovigilance Xuan Xu, Jessica Kawakami, Nuwan Indika Millagaha Gedara, Jim Riviere, Emma Meyer, Gerald J Wyckoff, Majid Jaberi-Douraki
167 [GO] eLife 2021―Oct―25 Effect of SARS-CoV-2 proteins on vascular permeability Rossana Rauti, Meishar Shahoha, Yael Leichtmann-Bardoogo, Rami Nasser, Eyal Paz, Rina Tamir, et al. (+9)
168 [GO] eLife 2021―Oct―18 Early prediction of in-hospital death of COVID-19 patients: a machine-learning model based on age, blood analyses, and chest x-ray score Emirena Garrafa, Marika Vezzoli, Marco Ravanelli, Davide Farina, Andrea Borghesi, Stefano Calza, Roberto Maroldi
169 [GO] eLife 2021―Oct―12 mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status Jason Neidleman, Xiaoyu Luo, Matthew McGregor, Guorui Xie, Victoria Murray, Warner C Greene, et al. (+2)
170 [GO] eLife 2021―Oct―05 HIV status alters disease severity and immune cell responses in beta variant SARS-CoV-2 infection wave Farina Karim, Inbal Gazy, Sandile Cele, Yenzekile Zungu, Robert Krause, Mallory Bernstein, et al. (+18)
171 [GO] eLife 2021―Sep―30 Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective Mona Seifert, Subhas C Bera, Pauline van Nies, Robert N Kirchdoerfer, Ashleigh Shannon, Thi-Tuyet-Nhung Le, et al. (+14)
172 [GO] eLife 2021―Sep―29 mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralisation of P.1 Brazilian variant Helen Parry, Gokhan Tut, Rachel Bruton, Sian Faustini, Christine Stephens, Philip Saunders, et al. (+19)
173 [GO] eLife 2021―Sep―28 Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants Elizabeth Jaworski, Rose M Langsjoen, Brooke Mitchell, Barbara Judy, Patrick Newman, Jessica A Plante, et al. (+18)
174 [GO] eLife 2021―Sep―27 Quantifying the relationship between SARS-CoV-2 viral load and infectiousness Aurélien Marc, Marion Kerioui, François Blanquart, Julie Bertrand, Oriol Mitjà, Marc Corbacho-Monné, et al. (+2)
175 [GO] eLife 2021―Aug―31 Sterically confined rearrangements of SARS-CoV-2 Spike protein control cell invasion Esteban Dodero-Rojas, Jose N Onuchic, Paul Charles Whitford
176 [GO] eLife 2021―Aug―26 Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand the human ACE2 receptor on binding affinity and kinetics Michael I Barton, Stuart A MacGowan, Mikhail A Kutuzov, Omer Dushek, Geoffrey J Barton, P Anton van der Merwe
177 [GO] eLife 2021―Aug―24 Superspreaders drive the largest outbreaks of hospital onset COVID-19 infections Christopher JR Illingworth, William L Hamilton, Ben Warne, Matthew Routledge, Ashley Popay, Chris Jackson, et al. (+34)
178 [GO] eLife 2021―Aug―20 SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19 Paul Z Chen, Niklas Bobrovitz, Zahra Premji, Marion Koopmans, David N Fisman, Frank X Gu
179 [GO] eLife 2021―Aug―20 Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia Alex R Schuurman, Tom DY Reijnders, Anno Saris, Ivan Ramirez Moral, Michiel Schinkel, Justin de Brabander, et al. (+6)
180 [GO] eLife 2021―Aug―20 N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2 Fang Tian, Bei Tong, Liang Sun, Shengchao Shi, Bin Zheng, Zibin Wang, et al. (+2)
181 [GO] eLife 2021―Aug―13 Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19 Courtney Tindle, MacKenzie Fuller, Ayden Fonseca, Sahar Taheri, Stella-Rita Ibeawuchi, Nathan Beutler, et al. (+15)
182 [GO] eLife 2021―Aug―13 Patterns of within-host genetic diversity in SARS-CoV-2 Gerry Tonkin-Hill, Inigo Martincorena, Roberto Amato, Andrew RJ Lawson, Moritz Gerstrung, Ian Johnston, et al. (+33)
183 [GO] eLife 2021―Aug―13 A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance Mohd Anisul, Jarrod Shilts, Jeremy Schwartzentruber, James Hayhurst, Annalisa Buniello, Elmutaz Shaikho, et al. (+12)
184 [GO] eLife 2021―Aug―12 A comprehensive look at the COVID-19 pandemic death toll Lone Simonsen, Cecile Viboud
185 [GO] eLife 2021―Aug―05 Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy Sierra M Barone, Alberta GA Paul, Lyndsey M Muehling, Joanne A Lannigan, William W Kwok, Ronald B Turner, et al. (+2)
186 [GO] eLife 2021―Aug―03 Within-host evolutionary dynamics of seasonal and pandemic human influenza A viruses in young children Alvin X Han, Zandra C Felix Garza, Matthijs RA Welkers, René M Vigeveno, Nhu Duong Tran, Thi Quynh Mai Le, et al. (+22)
187 [GO] eLife 2021―Jul―29 Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains Nikhil Faulkner, Kevin W Ng, Mary Y Wu, Ruth Harvey, Marios Margaritis, Stavroula Paraskevopoulou, et al. (+23)
188 [GO] eLife 2021―Jul―27 Identification of drugs associated with reduced severity of COVID-19 - a case-control study in a large population Ariel Israel, Alejandro A Schäffer, Assi Cicurel, Kuoyuan Cheng, Sanju Sinha, Eyal Schiff, et al. (+4)
189 [GO] eLife 2021―Jul―27 Revisiting the guidelines for ending isolation for COVID-19 patients Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, Shoya Iwanami, Ana I Bento, Yasuhisa Fujita, et al. (+7)
190 [GO] eLife 2021―Jul―12 Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time A Sarah Walker, Emma Pritchard, Thomas House, Julie V Robotham, Paul J Birrell, Iain Bell, et al. (+12)
191 [GO] eLife 2021―Jul―06 Mendelian randomization analysis provides causality of smoking on the expression of ACE2, a putative SARS-CoV-2 receptor Hui Liu, Junyi Xin, Sheng Cai, Xia Jiang
192 [GO] eLife 2021―Jun―30 Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset Ariel Karlinsky, Dmitry Kobak
193 [GO] eLife 2021―Jun―29 Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data Oliver Stirrup, Joseph Hughes, Matthew Parker, David G Partridge, James G Shepherd, James Blackstone, et al. (+10)
194 [GO] eLife 2021―Jun―24 Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries Katy A M Gaythorpe, Kaja Abbas, John Huber, Andromachi Karachaliou, Niket Thakkar, Kim Woodruff, et al. (+8)
195 [GO] eLife 2021―Jun―22 Smartphone Screen Testing, a novel pre-diagnostic method to identify SARS-CoV-2 infectious individuals Rodrigo M Young, Camila J Solis-Cascante, Andres Barriga-Fehrman, Carlos Abogabir, Alvaro R Thadani, Mariana Labarca, et al. (+13)
196 [GO] eLife 2021―Jun―21 Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice Seungjin Ryu, Irina Shchukina, Yun-Hee Youm, Hua Qing, Brandon Hilliard, Tamara Dlugos, et al. (+11)
197 [GO] eLife 2021―Jun―09 FnCas9 based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV2 variants on a paper strip Manoj Kumar, Sneha Gulati, Asgar H Ansari, Rhythm Phutela, Sundaram Acharya, Mohd Azhar, et al. (+9)
198 [GO] eLife 2021―Jun―04 Convalescent plasma use in the United States was inversely correlated with COVID-19 mortality Arturo Casadevall, Quigly Dragotakes, Patrick W Johnson, Jonathon W Senefeld, Stephen A Klassen, R Scott Wright, et al. (+3)
199 [GO] eLife 2021―May―27 A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs Eyad A Qunaibi, Mohamed Helmy, Iman Basheti, Iyad Sultan
200 [GO] eLife 2021―May―18 Avoiding culture shock with the SARS-CoV-2 spike protein Benjamin G Hale
201 [GO] eLife 2021―May―18 Modeling the impact of racial and ethnic disparities on COVID-19 epidemic dynamics Kevin C Ma, Tigist F Menkir, Stephen M Kissler, Yonatan H Grad, Marc Lipsitch
202 [GO] eLife 2021―May―04 Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population Heli Julkunen, Anna Cichońska, P Eline Slagboom, Peter Würtz
203 [GO] eLife 2021―Apr―27 Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-CoV-2 and other enveloped viruses Dylan H Morris, Kwe Claude Yinda, Amandine Gamble, Fernando W Rossine, Qishen Huang, Trenton Bushmaker, et al. (+7)
204 [GO] eLife 2021―Apr―26 High infectiousness immediately before COVID-19 symptom onset highlights the importance of continued contact tracing William Stephen Hart, Philip K Maini, Robin N Thompson
205 [GO] eLife 2021―Apr―23 SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation David W Sanders, Chanelle C Jumper, Paul J Ackerman, Dan Bracha, Anita Donlic, Hahn Kim, et al. (+13)
206 [GO] eLife 2021―Apr―20 Sensitivity of ID NOW and RT-PCR for detection of SARS-CoV-2 in an ambulatory population Yuan-Po Tu, Jameel Iqbal, Timothy O'Leary
207 [GO] eLife 2021―Apr―20 Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2 Salwa Naushin, Viren Sardana, Rajat Ujjainiya, Nitin Bhatheja, Rintu Kutum, Akash Kumar Bhaskar, et al. (+130)
208 [GO] eLife 2021―Apr―16 Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols Paul Z Chen, Niklas Bobrovitz, Zahra Premji, Marion Koopmans, David N Fisman, Frank X Gu
209 [GO] eLife 2021―Apr―09 Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation Mart M Lamers, Anna Z Mykytyn, Tim I Breugem, Yiquan Wang, Douglas C Wu, Samra Riesebosch, et al. (+5)
210 [GO] eLife 2021―Apr―08 Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection Nick K Jones, Lucy Rivett, Shaun Seaman, Richard J Samworth, Ben Warne, Chris Workman, et al. (+10)
211 [GO] eLife 2021―Mar―30 Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage Stefanie Deinhardt-Emmer, Daniel Wittschieber, Juliane Sanft, Sandra Kleemann, Stefan Elschner, Karoline Frieda Haupt, et al. (+11)
212 [GO] eLife 2021―Mar―29 Saliva TwoStep for rapid detection of asymptomatic SARS-CoV-2 carriers Qing Yang, Nicholas R Meyerson, Stephen K Clark, Camille L Paige, Will T Fattor, Alison R Gilchrist, et al. (+19)
213 [GO] eLife 2021―Mar―23 Rare variants increase the risk of severe COVID-19 Frank L van de Veerdonk, Mihai G Netea
214 [GO] eLife 2021―Mar―23 Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation Florence WJ Chioh, Siew-Wai Fong, Barnaby E Young, Kan-Xing Wu, Anthony Siau, Shuba Krishnan, et al. (+13)
215 [GO] eLife 2021―Mar―17 Genomic and healthcare dynamics of nosocomial SARS-CoV-2 transmission Jamie M Ellingford, Ryan George, John H McDermott, Shazaad Ahmad, Jonathan J Edgerley, David Gokhale, et al. (+4)
216 [GO] eLife 2021―Mar―11 Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death Jack Gisby, Candice L Clarke, Nicholas Medjeral-Thomas, Talat H Malik, Artemis Papadaki, Paige M Mortimer, et al. (+19)
217 [GO] eLife 2021―Mar―08 An open label trial of anakinra to prevent respiratory failure in COVID-19 Evdoxia Kyriazopoulou, Periklis Panagopoulos, Symeon Metallidis, George N Dalekos, Garyphallia Poulakou, Nikolaos Gatselis, et al. (+33)
218 [GO] eLife 2021―Mar―08 SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung Alan E Mast, Alisa S Wolberg, David Gailani, Michael R Garvin, Christiane Alvarez, J Izaak Miller, et al. (+2)
219 [GO] eLife 2021―Mar―05 Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys Daniel B Larremore, Bailey K Fosdick, Kate M Bubar, Sam Zhang, Stephen M Kissler, C Jessica E Metcalf, et al. (+2)
220 [GO] eLife 2021―Mar―02 Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study Chiara Fallerini, Sergio Daga, Stefania Mantovani, Elisa Benetti, Nicola Picchiotti, Daniela Francisci, et al. (+19)
221 [GO] eLife 2021―Mar―02 Genomic epidemiology of COVID-19 in care homes in the East of England William L Hamilton, Gerry Tonkin-Hill, Emily R Smith, Dinesh Aggarwal, Charlotte J Houldcroft, Ben Warne, et al. (+31)
222 [GO] eLife 2021―Feb―23 COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest Albert Tian Chen, Kevin Altschuler, Shing Hei Zhan, Yujia Alina Chan, Benjamin E Deverman
223 [GO] eLife 2021―Feb―23 Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events Ashish Goyal, Daniel B Reeves, E Fabian Cardozo-Ojeda, Joshua T Schiffer, Bryan T Mayer
224 [GO] eLife 2021―Feb―16 Antimicrobial resistance and COVID-19: Intersections and implications Gwenan M Knight, Rebecca E Glover, C Finn McQuaid, Ioana D Olaru, Karin Gallandat, Quentin J Leclerc, et al. (+5)
225 [GO] eLife 2021―Feb―11 The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types Zharko Daniloski, Tristan X Jordan, Juliana K Ilmain, Xinyi Guo, Gira Bhabha, Benjamin R tenOever, Neville E Sanjana
226 [GO] eLife 2021―Feb―08 SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets Palur V Raghuvamsi, Nikhil Kumar Tulsian, Firdaus Samsudin, Xinlei Qian, Kiren Purushotorman, Gu Yue, et al. (+6)
227 [GO] eLife 2021―Feb―05 Quantifying the impact of quarantine duration on COVID-19 transmission Peter Ashcroft, Sonja Lehtinen, Daniel C Angst, Nicola Low, Sebastian Bonhoeffer
228 [GO] eLife 2021―Jan―19 Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229E Kathryn E Kistler, Trevor Bedford
229 [GO] eLife 2021―Jan―14 Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2 Kelsey E Huntington, Anna D Louie, Chun Geun Lee, Jack A Elias, Eric A Ross, Wafik S El-Deiry
230 [GO] eLife 2021―Jan―05 Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T cell memory formation after mild COVID-19 infection Anastasia A Minervina, Ekaterina A Komech, Aleksei Titov, Meriem Bensouda Koraichi, Elisa Rosati, Ilgar Z Mamedov, et al. (+7)
231 [GO] eLife 2021―Jan―04 SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site Anna Z Mykytyn, Tim I Breugem, Samra Riesebosch, Debby Schipper, Petra B van den Doel, Robbert J Rottier, et al. (+2)
232 [GO] eLife 2020―Dec―17 Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring AMR bacterial pneumonia Michaela Gregorova, Daniel Morse, Tarcisio Brignoli, Joseph Steventon, Fergus Hamilton, Mahableshwar Albur, et al. (+24)
233 [GO] eLife 2020―Dec―15 Neutralizing SARS-CoV-2 Eric Poeschla
234 [GO] eLife 2020―Nov―26 A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study Joachim Linssen, Anthony Ermens, Marvin Berrevoets, Michela Seghezzi, Giulia Previtali, Simone van der Sar-van der Brugge, et al. (+17)
235 [GO] eLife 2020―Nov―24 COVID-19 research risks ignoring important host genes due to pre-established research patterns Thomas Stoeger, Luís A Nunes Amaral
236 [GO] eLife 2020―Nov―09 ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities Natalia Zamorano Cuervo, Nathalie Grandvaux
237 [GO] eLife 2020―Nov―09 Single cell multiomic profiling of human lung reveals cell type-specific and age-dynamic control of SARS-CoV2 host genes Allen Wang, Joshua Chiou, Olivier B Poirion, Justin Buchanan, Michael J Valdez, Jamie M Verheyden, et al. (+20)
238 [GO] eLife 2020―Oct―28 Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio CC Lorenzi, et al. (+18)
239 [GO] eLife 2020―Oct―26 Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration Qi Yang, Thomas A Hughes, Anju Kelkar, Xinheng Yu, Kai Cheng, Sheldon Park, et al. (+3)
240 [GO] eLife 2020―Oct―12 Early prediction of level-of-care requirements in patients with COVID-19 Boran Hao, Shahabeddin Sotudian, Taiyao Wang, Tingting Xu, Yang Hu, Apostolos Gaitanidis, et al. (+3)
241 [GO] eLife 2020―Oct―01 Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic Chase W Nelson, Zachary Ardern, Tony L Goldberg, Chen Meng, Chen-Hao Kuo, Christina Ludwig, et al. (+2)
242 [GO] eLife 2020―Sep―15 Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions Ilja L Kruglikov, Manasi Shah, Philipp E Scherer
243 [GO] eLife 2020―Sep―07 Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset Benny Borremans, Amandine Gamble, K C Prager, Sarah K Helman, Abby M McClain, Caitlin Cox, et al. (+2)
244 [GO] eLife 2020―Aug―24 The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship Jon C Emery, Timothy W Russell, Yang Liu, Joel Hellewell, Carl AB Pearson, Gwenan M Knight, et al. (+5)
245 [GO] eLife 2020―Aug―21 Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study David W Eyre, Sheila F Lumley, Denise O'Donnell, Mark Campbell, Elizabeth Sims, Elaine Lawson, et al. (+45)
246 [GO] eLife 2020―Aug―20 3d virtual pathohistology of lung tissue from COVID-19 patients based on phase contrast x-ray tomography Marina Eckermann, Jasper Frohn, Marius Reichardt, Markus Osterhoff, Michael Sprung, Fabian Westermeier, et al. (+4)
247 [GO] eLife 2020―Aug―17 Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC) Colin Pawlowski, Tyler Wagner, Arjun Puranik, Karthik Murugadoss, Liam Loscalzo, AJ Venkatakrishnan, et al. (+13)
248 [GO] eLife 2020―Aug―13 Early analysis of the Australian COVID-19 epidemic David J Price, Freya M Shearer, Michael T Meehan, Emma McBryde, Robert Moss, Nick Golding, et al. (+7)
249 [GO] eLife 2020―Jul―30 Neuropathogenesis of SARS-CoV-2 infection Shumayila Khan, James Gomes
250 [GO] eLife 2020―Jul―14 Does the human placenta express the canonical cell entry mediators for SARS-CoV-2? Roger Pique-Regi, Roberto Romero, Adi L Tarca, Francesca Luca, Yi Xu, Adnan Alazizi, et al. (+3)
251 [GO] eLife 2020―Jul―07 Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis Tyler Wagner, FNU Shweta, Karthik Murugadoss, Samir Awasthi, AJ Venkatakrishnan, Sairam Bade, et al. (+26)
252 [GO] eLife 2020―Jul―07 A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm Mike R Garvin, Christiane Alvarez, J Izaak Miller, Erica T Prates, Angelica M Walker, B Kirtley Amos, et al. (+4)
253 [GO] eLife 2020―Jun―23 Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization PJ Klasse, John P Moore
254 [GO] eLife 2020―Jun―22 Evidence for transmission of COVID-19 prior to symptom onset Lauren C Tindale, Jessica E Stockdale, Michelle Coombe, Emma S Garlock, Wing Yin Venus Lau, Manu Saraswat, et al. (+4)
255 [GO] eLife 2020―Jun―19 Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19 Nick K Jones, Lucy Rivett, Dominic Sparkes, Sally Forrest, Sushmita Sridhar, Jamie Young, et al. (+28)
256 [GO] eLife 2020―Jun―15 Meta-Research: COVID-19 medical papers have fewer women first authors than expected Jens Peter Andersen, Mathias Wullum Nielsen, Nicole L Simone, Resa E Lewiss, Reshma Jagsi
257 [GO] eLife 2020―Jun―08 A Global Immunological Observatory to meet a time of pandemics Michael J Mina, C Jessica E Metcalf, Adrian B McDermott, Daniel C Douek, Jeremy Farrar, Bryan T Grenfell
258 [GO] eLife 2020―May―28 Knowledge synthesis of 100 million biomedical documents augments the deep expression profiling of coronavirus receptors AJ Venkatakrishnan, Arjun Puranik, Akash Anand, David Zemmour, Xiang Yao, Xiaoying Wu, et al. (+12)
259 [GO] eLife 2020―May―26 SARS-CoV-2 strategically mimics proteolytic activation of human ENaC Praveen Anand, Arjun Puranik, Murali Aravamudan, AJ Venkatakrishnan, Venky Soundararajan
260 [GO] eLife 2020―May―11 Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission Lucy Rivett, Sushmita Sridhar, Dominic Sparkes, Matthew Routledge, Nick K Jones, Sally Forrest, et al. (+20)
261 [GO] eLife 2020―Apr―27 Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome Frank L van de Veerdonk, Mihai G Netea, Marcel van Deuren, Jos WM van der Meer, Quirijn de Mast, Roger J Brüggemann, Hans van der Hoeven
262 [GO] eLife 2020―Apr―06 Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients Gian Paolo Rossi, Viola Sanga, Matthias Barton
263 [GO] eLife 2020―Mar―31 SARS-CoV-2 (COVID-19) by the numbers Yinon M Bar-On, Avi Flamholz, Rob Phillips, Ron Milo
264 [GO] eLife 2020―Mar―25 Publishing in the time of COVID-19 Michael B Eisen, Anna Akhmanova, Timothy E Behrens, Detlef Weigel
265 [GO] eLife 2020―Feb―24 Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19 Katelyn Gostic, Ana C R Gomez, Riley O Mummah, Adam J Kucharski, James O Lloyd-Smith
 [1] 

265 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.027 sec